107 related articles for article (PubMed ID: 22800301)
21. Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: targets for cytoprotective hydrazino drugs.
Kaminskas LM; Pyke SM; Burcham PC
Rapid Commun Mass Spectrom; 2007; 21(7):1155-64. PubMed ID: 17318925
[TBL] [Abstract][Full Text] [Related]
22. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
[TBL] [Abstract][Full Text] [Related]
23. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.
Mendez AJ; Anantharamaiah GM; Segrest JP; Oram JF
J Clin Invest; 1994 Oct; 94(4):1698-705. PubMed ID: 7929849
[TBL] [Abstract][Full Text] [Related]
24. 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages.
Pirillo A; Uboldi P; Kuhn H; Catapano AL
Biochim Biophys Acta; 2006 Mar; 1761(3):292-300. PubMed ID: 16647293
[TBL] [Abstract][Full Text] [Related]
25. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
[TBL] [Abstract][Full Text] [Related]
26. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
[TBL] [Abstract][Full Text] [Related]
27. [Effect of apolipoprotein A-I mimetic peptides on cholesterol efflux in RAW264.7 cells].
Xie Q; Zhao S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 36(1):51-7. PubMed ID: 21311139
[TBL] [Abstract][Full Text] [Related]
28. Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages.
Uto-Kondo H; Ayaori M; Ogura M; Nakaya K; Ito M; Suzuki A; Takiguchi S; Yakushiji E; Terao Y; Ozasa H; Hisada T; Sasaki M; Ohsuzu F; Ikewaki K
Circ Res; 2010 Mar; 106(4):779-87. PubMed ID: 20075335
[TBL] [Abstract][Full Text] [Related]
29. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.
Diditchenko S; Gille A; Pragst I; Stadler D; Waelchli M; Hamilton R; Leis A; Wright SD
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2202-11. PubMed ID: 23868939
[TBL] [Abstract][Full Text] [Related]
30. Reactivity with Tris(hydroxymethyl)aminomethane confounds immunodetection of acrolein-adducted proteins.
Burcham PC; Fontaine FR; Petersen DR; Pyke SM
Chem Res Toxicol; 2003 Oct; 16(10):1196-201. PubMed ID: 14565760
[TBL] [Abstract][Full Text] [Related]
31. A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity.
Zhao W; Du F; Zhang M; Sun S; Yu H; Fan D
Exp Biol Med (Maywood); 2011 Dec; 236(12):1468-76. PubMed ID: 22087021
[TBL] [Abstract][Full Text] [Related]
32. Lysine residues of ABCA1 are required for the interaction with apoA-I.
Nagao K; Kimura Y; Ueda K
Biochim Biophys Acta; 2012 Mar; 1821(3):530-5. PubMed ID: 21749932
[TBL] [Abstract][Full Text] [Related]
33. Acrolein impairs the cholesterol transport functions of high density lipoproteins.
Chadwick AC; Holme RL; Chen Y; Thomas MJ; Sorci-Thomas MG; Silverstein RL; Pritchard KA; Sahoo D
PLoS One; 2015; 10(4):e0123138. PubMed ID: 25849485
[TBL] [Abstract][Full Text] [Related]
34. Incorporation of α-methylated amino acids into Apolipoprotein A-I mimetic peptides improves their helicity and cholesterol efflux potential.
Islam R; Sviridov DO; Drake SK; Tunyi J; Abdoulaeva G; Freeman LA; Pastor RW; Remaley AT
Biochem Biophys Res Commun; 2020 May; 526(2):349-354. PubMed ID: 32222278
[TBL] [Abstract][Full Text] [Related]
35. ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain.
Wang N; Yvan-Charvet L; Lütjohann D; Mulder M; Vanmierlo T; Kim TW; Tall AR
FASEB J; 2008 Apr; 22(4):1073-82. PubMed ID: 18039927
[TBL] [Abstract][Full Text] [Related]
36. Cellular Uptake and Clearance of Oxidatively-modified Apolipoprotein E3 by Cerebral Cortex Endothelial Cells.
Cruz S; Narayanaswami V
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533203
[TBL] [Abstract][Full Text] [Related]
37. Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-γ/LXR-α signaling pathway.
Xu X; Li Q; Pang L; Huang G; Huang J; Shi M; Sun X; Wang Y
Biochem Biophys Res Commun; 2013 Nov; 441(2):321-6. PubMed ID: 24140409
[TBL] [Abstract][Full Text] [Related]
38. A Photo-Activatable Peptide Mimicking Functions of Apolipoprotein A-I.
Kawahara H; Miyashita N; Tachibana K; Tsuda Y; Morimoto K; Tsuji K; Shigenaga A; Otaka A; Ishida T; Okuhira K
Biol Pharm Bull; 2019; 42(6):1019-1024. PubMed ID: 31155576
[TBL] [Abstract][Full Text] [Related]
39. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function.
Peng DQ; Brubaker G; Wu Z; Zheng L; Willard B; Kinter M; Hazen SL; Smith JD
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2063-70. PubMed ID: 18688016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
